Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan - Iran

被引:80
作者
Alizadeh, Amir Houshang Mohammad [1 ]
Alavian, Seyed Moayed [2 ]
Jafari, Khalil [3 ]
Yazdi, Nastaran [3 ]
机构
[1] Shaheed Beheshti Univ Med Sci, Res Ctr Gastroenterol & Liver Dis, Tehran 19857, Iran
[2] Baghiatalah Univ Med Sci, Tehran, Iran
[3] Hamedan Univ Med Sci, Hamadan, Iran
关键词
Hepatitis C virus; Prisoners; Drug abusers; Iran;
D O I
10.3748/wjg.v11.i26.4085
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: Recent studies in Iran has shown that prevalence of hepatitis C virus (HCV) infection among Iranian prisoners is high, in spite of low HCV seroprevalence in general population. METHODS: This study was carried out in the central prison of Hamedan - Iran, in year 2002. Inmates were interviewed using a standard questionnaire including demographic, imprisonment history and HCV-related risk behaviors items. Thereafter, the sera drawn from the participants were tested for anti-HIV and anti-HCV antibodies. RESULTS: A total number of 427 drug abuser inmates participated in our study. Three hundred and ninety-seven (93%) were men and 30 (7%) were women. Total number of IV drug abusers (IDA) and non-IV drug abusers (NIDA) was 149 (34.9%) and 278 (65.1%), respectively. The overall rate of antibody positivity among inmates was 0.9% for HIV and 30% for HCV. Of all IDAs, 31.5% and of NIDAs, 29.1% had serological evidence of HCV infection. CONCLUSION: The seroprevalence of HCV infection among drug abuser prisoners in comparison with the general population in Iran, is very high (30% vs in italics 0.2%). Our results indicate the importance of policies to prevent transmission of HCV infection during and following incarceration. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:4085 / 4089
页数:5
相关论文
共 48 条
  • [1] Hepatitis C risk factors in Iranian volunteer blood donors: A case-control study
    Alavian, SM
    Gholami, B
    Masarrat, S
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (10) : 1092 - 1097
  • [2] Treatment of chronic hepatitis C in a state correctional facility
    Allen, SA
    Spaulding, AC
    Osei, AM
    Taylor, LE
    Cabral, AM
    Rich, JD
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (03) : 187 - 190
  • [3] Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey
    Allwright, S
    Bradley, F
    Long, J
    Barry, J
    Thornton, L
    Parry, JV
    [J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7253) : 78 - 82
  • [4] Alter HJ, 1997, HEPATOLOGY S1, V26, P29
  • [5] THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES
    ALTER, MJ
    MARGOLIS, HS
    KRAWCZYNSKI, K
    JUDSON, FN
    MARES, A
    ALEXANDER, WJ
    HU, PY
    MILLER, JK
    GERBER, MA
    SAMPLINER, RE
    MEEKS, EL
    BEACH, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) : 1899 - 1905
  • [6] Hepatitis C virus infection in the United States
    Alter, MJ
    [J]. JOURNAL OF HEPATOLOGY, 1999, 31 : 88 - 91
  • [7] ALTER MJ, 1997, HEPATOLOGY S1, V26, P62
  • [8] Prevalence of HIV and injecting drug use in men entering Liverpool prison
    Bellis, MA
    Weild, AR
    Beeching, NJ
    Mutton, KJ
    Syed, Q
    [J]. BRITISH MEDICAL JOURNAL, 1997, 315 (7099) : 30 - 31
  • [9] STUDY OF INFECTION WITH HIV AND RELATED RISK-FACTORS IN YOUNG OFFENDERS INSTITUTION
    BIRD, AG
    GORE, SM
    BURNS, SM
    DUGGIE, JG
    [J]. BRITISH MEDICAL JOURNAL, 1993, 307 (6898) : 228 - 231
  • [10] Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison
    Burattini, MN
    Massad, E
    Rozman, M
    Azevedo, RS
    Carvalho, HB
    [J]. REVISTA DE SAUDE PUBLICA, 2000, 34 (05): : 431 - 436